Executive leadership at Zivo Bioscience.
Board of directors at Zivo Bioscience.
Research analysts covering Zivo Bioscience.
Recent press releases and 8-K filings for ZIVO.
Zivo Bioscience Announces CFO Resignation and Interim Replacement
ZIVO
CFO Change
Management Change
Executive Compensation
- Zivo Bioscience, Inc. announced the resignation of its Chief Financial Officer, Keith R. Marchiando, effective immediately on December 19, 2025, with his employment concluding on December 31, 2025.
- In connection with his separation, Mr. Marchiando will receive his current salary of $27,040 per month until December 31, 2026, and will retain options to acquire 150,000 shares at an exercise price of $7.96 per share, exercisable until June 30, 2027.
- William A. Sullivan has been appointed as the Interim Chief Financial Officer, effective December 19, 2025, and will be compensated at a rate of $285.00 per hour as an independent contractor.
Dec 23, 2025, 9:06 PM
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more